Download Global Vaccines 202X_DoV Overview_Elias

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Neglected tropical diseases wikipedia , lookup

African trypanosomiasis wikipedia , lookup

Whooping cough wikipedia , lookup

Pandemic wikipedia , lookup

Neisseria meningitidis wikipedia , lookup

Meningococcal disease wikipedia , lookup

Syndemic wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Transcript
Overview
A brief history….
• World Economic Forum, January 2010
– Bill and Melinda Gates highlight that 8-10 million deaths can be
prevented in the next decade.
– The Bill & Melinda Gates Foundation commits $10 billion and
challenges others to join them in bringing the benefits of
immunization to all people, regardless of where they live.
• WHO, UNICEF and BMGF initiate Decade of Vaccines planning
– Pedro Alonso (Institute for Global Health, Barcelona) and Chris Elias
(PATH) asked to lead the planning effort.
• The Decade of Vaccines Collaboration
– An effort to create a Global Vaccine Action Plan
– Establishes a collaborative structure to engage diverse stakeholders.
– Target completion: mid-2012
Decade of Vaccines Collaboration
International Advisory
Committee
Leadership Council
Steering Committee
Co-Chairs:
Prof. Pedro Alonso
Dr. Christopher Elias
At-Large Steering Committee Members
Secretariat
Public and Political
Support Co-Chairs
Delivery
Co-Chairs
R&D
Co-Chairs
Global Access CoChairs
Public and Political
Support Working
Group
Delivery Working
Group
R&D
Working Group
Global Access
Working Group
Leadership Council
Dr. Margaret Chan
Mr. Anthony Lake
Dr. Anthony Fauci
Dr. Tachi Yamada
Director General
World Health Organization
Director, National Institute
of Allergy and Infectious
Diseases
Executive Director
UNICEF
President of Global Health
Bill & Melinda Gates
Foundation
Ms. Joy Phumaphi
Executive Secretary
African Leaders Malaria
Alliance
Steering Committee:
Co-Chairs and Working Groups
Delivery
R&D
Steering Committee
Dr. Jean Marie
Okwo-Bele
Prof. Pedro
Alonso
Dr. Christopher
Elias
Dr. Jos
Vandelaer
Public and Political
Support
Dr. Nicole
Bates
Dr. Peter
Singer
Dr. Seth
Berkley
Dr. David
Salisbury
Global Access
Ms. Sandy
Wrobel
Dr. Orin
Levine
Steering Committee: At-Large
Dr. T. Jacob
John
Dr. Zulfiqar
Bhutta
Dr. Lucky
Slamet
Dr. Lola
Dare
Dr. Anne
Schucat
Ms. Helen
Evans
Dr. Ciro de
Quadros
Dr. Lee Hall
Dr. Gina
Tambini
Decade of Vaccines Vision
We envision a world where children, families, and
communities enjoy life protected from the threat
of preventable disease.
Recognizing that immunization is one of the most
cost-effective means to achieve this vision, the
purpose of the Decade of Vaccines is to extend the
full benefits of immunization to all people,
regardless of where they live. Access to safe and
effective vaccines is a human right that is currently
not enjoyed by everyone, particularly in low and
middle-income countries.
Global Vaccine Action Plan Goals
1. Achieve global eradication and elimination goals agreed by
the World Health Assembly for vaccine-preventable disease.
•
Polio, Measles, Rubella, and Neonatal tetanus, etc.
2. In every country, reduce the incidence of vaccine-preventable
diseases such that they are no longer public health problems
in 2020.
•
•
•
•
Routine immunizations: DTP, Hib, Hep B
New and underutilized: HPV, Rota, Pneumo
Regional or high risk populations: MenA, JE, Yellow Fever, Typhoid,
Cholera, Hep A, Rabies
Countries choose their own priorities but must achieve universal
coverage in every district and demonstrate reductions in disease
incidence/burden
3. Maximize the contribution of immunization programs to
integrated disease control and health efforts.
•
ALRI, Diarrheal disease, cervical cancer, malaria, TB, seasonal flu
Global Vaccine Action Plan Goals
4.
Encourage a robust scientific enterprise to ensure a continuous
improvement in immunization strategies and produce innovation in
the development of new and improved vaccines for high priority
disease targets.
•
•
•
Short-term, operational research to improve coverage, reduce vaccine
wastage, lower delivery costs, etc.
Mid-term translational research to increase % of vaccines out of cold
chain, develop second-generation lower cost vaccines, or register and
prequalify new vaccine candidates
Long-term vaccinology and immunology research to advance HIV or TB
vaccines, etc.
5. Ensure adequate and sustained support for vaccines and
immunizations.
•
•
•
Financial and human resources
Country-level advocacy/demand, ownership and planning
Disease surveillance and monitoring
Decade of Vaccines Collaboration
International Advisory
Committee
Leadership Council
Steering Committee
Co-Chairs:
Prof. Pedro Alonso
Dr. Christopher Elias
At-Large Steering Committee Members
Secretariat
Public and Political
Support Co-Chairs
Delivery
Co-Chairs
R&D
Co-Chairs
Global Access CoChairs
Public and Political
Support Working
Group
Delivery Working
Group
R&D
Working Group
Global Access
Working Group